Preferred Label : B7-H1 Antigen;
MeSH definition : An inhibitory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL
DEATH 1 PROTEIN. CD274 antigen provides negative signals that control and inhibit
T-cell responses and is found at higher than normal levels on tumor cells, suggesting
its potential role in TUMOR IMMUNE EVASION.; An inhibitory B7 antigen that contains V-type and C2 type immunoglobulin domains.
It has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 PROTEIN and provides
negative signals that control and inhibit T-cell responses. It is found at higher
than normal levels on tumor cells, suggesting its potential role in TUMOR IMMUNE EVASION.;
MeSH synonym : CD274 antigens; B7-H1 immune costimulatory protein; B7 H1 immune costimulatory protein; programmed cell death 1 ligand 1 protein; CD274 antigen; antigen, CD274; PD-L1 costimulatory protein; costimulatory protein, PD-L1; PD L1 costimulatory protein; programmed cell death 1 ligand 1; antigen, B7-H1; B7 H1 antigen; B7H1 immune costimulatory protein; Antigens, CD274; Programmed Death Ligand 1; PD-L1 Protein; PD L1 Protein;
Is substance : O;
Origin ID : D060890;
UMLS CUI : C3203086;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Indexing information
Record concept(s)
Related MeSH Supplementary Concept(s)
See also
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
An inhibitory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL
DEATH 1 PROTEIN. CD274 antigen provides negative signals that control and inhibit
T-cell responses and is found at higher than normal levels on tumor cells, suggesting
its potential role in TUMOR IMMUNE EVASION.
An inhibitory B7 antigen that contains V-type and C2 type immunoglobulin domains.
It has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 PROTEIN and provides
negative signals that control and inhibit T-cell responses. It is found at higher
than normal levels on tumor cells, suggesting its potential role in TUMOR IMMUNE EVASION.
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/posologie-des-anticorps-monoclonaux-ciblant-le-pd-1-ou-le-pd-l1.html
2023
false
false
false
Canada
programmed cell death 1 receptor
Nivolumab
pembrolizumab
antibodies, monoclonal, humanized
atezolizumab
avelumab
cemiplimab
durvalumab
guidelines for drug use
antibodies, monoclonal
antibodies, monoclonal
B7-H1 Antigen
---
https://pgtmsite.files.wordpress.com/2024/01/ad-pembro_rapport-final1.pdf
2022
Canada
drug information
neoplasm, malignant
quebec
pembrolizumab
carcinoma, non-small-cell lung
Nonmetastatic
CYRIB wt Allele
L1 Stage Finding
Metastatic
Daur Chinese
lupus erythematosus cell
Lower Esophageal Sphincter
Lung Non-Small Cell Carcinoma
metastatic to
L1 Mouse
small cell lung carcinoma
patients
Patient
has patient
LE cells
Due
Long Interspersed Nucleotide Element-1
Pembrolizumab
Identifier
Intent To Treat
Device-In-Use Domain
Metastatic Malignant Neoplasm
Deoxyuridine
B7-H1 Antigen
pembrolizumab
pembrolizumab
intention to treat analysis
Analysis
hospitals, university
neutrophils
Cancer Therapeutic Procedure
Analyzed
Description
INRG Stage L1
---